MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Waters Corporation Depreciation & Amortization 2011-2026 | WAT
Annual Depreciation & Amortization Waters Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88.1 M | 87 M | 84.6 M | 72 M | 71.6 M | 68.7 M | 53.8 M | 58 M | 61.4 M | 51.7 M | 45.3 M | 46.4 M | 38.2 M | 37.4 M | 36.5 M | 34.4 M | 31.8 M | 29.1 M | 27.5 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 88.1 M | 27.5 M | 53.9 M |
Quarterly Depreciation & Amortization Waters Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 36 M | 30 M | 29 M | 21.7 M | - | 28 M | 25 M | 22.1 M | - | 26 M | 18 M | 19.4 M | - | 54.3 M | - | 17.2 M | - | 52.8 M | - | 16.3 M | - | 49.4 M | 33.2 M | 15.7 M | - | 42.2 M | 28.7 M | 12 M | - | 44.7 M | 30.6 M | 16.1 M | - | 45.5 M | 30.8 M | 12.8 M | - | 38.9 M | 26.1 M | 12.4 M | - | 33.2 M | 22.8 M | 11.4 M | - | 34.7 M | 17.3 M | 8.82 M | - | 27.8 M | 18.1 M | 8.49 M | - | 27.1 M | 17.2 M | 7.76 M | - | 27.3 M | 17.9 M | 8.64 M | 25.9 M | 17.1 M | 8.44 M | 23.8 M | 16.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 54.3 M | 7.76 M | 24.8 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 18.56 | 10.74 % | $ 196 M |  China |
 |
Agilent Technologies
A
|
321 M | - | - | $ 34.4 B |  USA |
 |
Castle Biosciences
CSTL
|
40.8 M | $ 18.88 | 4.02 % | $ 547 M | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 16.19 | 1.44 % | $ 490 M | USA |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 20.49 | -0.58 % | $ 1.09 B | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 419.17 | -1.08 % | $ 12.1 B | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
70.1 M | - | - | $ 6.5 B | USA |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 041.91 | 1.75 % | $ 21.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 3.62 | -2.95 % | $ 335 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
1.11 M | $ 1.63 | 1.87 % | $ 2.17 M | USA |
 |
NeoGenomics
NEO
|
36.1 M | $ 8.36 | 1.21 % | $ 1.07 B | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 18.93 | 1.39 % | $ 424 M | USA |
 |
Natera
NTRA
|
16.7 M | $ 196.91 | 0.81 % | $ 19.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 159.12 | -2.29 % | $ 7.89 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 25.5 | -0.51 % | $ 24.2 B |  Niderland |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
Personalis
PSNL
|
10 M | $ 6.71 | 5.01 % | $ 599 M | USA |
 |
Guardant Health
GH
|
39.7 M | $ 98.66 | 0.19 % | $ 12.4 B | USA |
 |
Senseonics Holdings
SENS
|
1.51 M | $ 5.82 | 5.82 % | $ 243 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 117.09 | -0.25 % | $ 9.66 B |  Irlanda |
 |
Illumina
ILMN
|
354 M | $ 143.24 | -1.21 % | $ 22.8 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.02 M | $ 52.99 | 0.08 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | Niderland |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 52.95 | -2.65 % | $ 3.17 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.41 | 7.11 % | $ 5.54 M | USA |
 |
Thermo Fisher Scientific
TMO
|
1.05 B | $ 448.21 | 0.49 % | $ 169 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 254.02 | -0.16 % | $ 21.1 B | USA |
 |
Celcuity
CELC
|
167 K | $ 134.72 | 8.23 % | $ 6.3 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
119 M | $ 8.43 | -2.99 % | $ 1.83 B | USA |